Boston Scientific reaches preliminary settlement
Boston Scientific Corp (NYSE:BSX), a $144.82 billion medical device manufacturer with strong financial health according to InvestingPro analysis, has received preliminary court approval for a ...
News Medical2d
Pittcon to make historic first appearance in Boston’s world-leading scientific hub
Pittcon 2025 in Boston: a landmark event uniting industry and academia to advance analytical chemistry and foster groundbreaking scientific collaboration.
MassDevice3d
Boston Scientific expects Farapulse, Watchman to drive 2025 growth
With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...
Boston Scientific Standing Apart As A Rare Med-Tech Growth Story
Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...